BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 32483459)

  • 21. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
    Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
    J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orchestrating Precision within the Tumor Microenvironment by Biomimetic Nanoprodrugs for Effective Tumor Therapy.
    Wang Y; Xu H; Huang X; Zhang Y; Lu Y; Cheng J; Xu X; Li J; Yao H; Chen X
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8484-8498. PubMed ID: 38334265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.
    Li H; Liu B; Ao H; Fu J; Wang Y; Feng Y; Guo Y; Wang X
    J Nanobiotechnology; 2020 Jan; 18(1):4. PubMed ID: 31907045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
    Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
    J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases.
    Xu X; Han Y; Deng J; Wang S; Zhuo S; Zhao K; Zhou W
    Acta Pharm Sin B; 2024 Jun; 14(6):2698-2715. PubMed ID: 38828135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.
    Xiao C; Li J; Wang X; Li S; Xu C; Zhang Z; Hua A; Ding ZY; Zhang BX; Yang X; Li Z
    J Control Release; 2023 Apr; 356():288-305. PubMed ID: 36870542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
    Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
    McMahon A; Chen W; Li F
    J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer.
    Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S
    Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET.
    Kanellis DC; Zisi A; Skrott Z; Lemmens B; Espinoza JA; Kosar M; Björkman A; Li X; Arampatzis S; Bartkova J; Andújar-Sánchez M; Fernandez-Capetillo O; Mistrik M; Lindström MS; Bartek J
    Cell Death Differ; 2023 Jul; 30(7):1666-1678. PubMed ID: 37142656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy.
    Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q
    Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
    Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
    J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of disulfiram and copper for cancer treatment.
    Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
    Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.